AZ Sees China Digital Health Blossoming Post-Coronavirus
Executive Summary
'Internet hospitals', electronic prescriptions and online physician and patient education are likely to see increasing importance in a post-coronavirus China, says AstraZeneca's emerging markets head.
You may also be interested in...
Volume-Based Purchasing Looms Larger In Post-Coronavirus China
China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.
AstraZeneca: ‘Firing On All Cylinders’ In Q3
AstraZeneca beat market forecasts when posting its fifth successive quarter of revenue growth – but the UK drug maker warned that its sales in China will now slow down.
Lost In Translation? New Zoonotic Virus Naming Gets China's Largest Physician Platform In Trouble
China's largest physician portal DXY has been banned from posting on a major social media platform after naming a new zoonotic virus after the place where it originated.